Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 50 out of 100. Genetics

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

= 0.006). Univariable MR analyses indicated that education and participation reduced the risk of AD. However, MR also suggested that education increased the risk of AD/ADRD, highlighting the inconsistencies between clinical and proxy diagnoses of AD, as proxy-AD may be affected by selection, collider, or ascertainment bias. MVMR suggested that education remained associated with reduced AD risk after adjusting for participation and the protective effect of education may be due to other biological mechanisms, such as cognitive reserve.

What this study adds

Evidence grade: High

This is a pooled review. This Mendelian randomization analysis suggested education and participation reduced Alzheimer disease risk, while education also appeared to increase risk of AD/ADRD, which the authors attribute to inconsistencies between clinical and proxy diagnoses. The authors suggest the protective effect of education may be due to other biological mechanisms such as cognitive reserve, and no treatment was tested.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Chatterjee, A., Cavaillès, C., Davies, N. M., Yaffe, K. S., & Andrews, S. J. (2025). Disentangling the Causal Effects of Education and Participation Bias on Alzheimer Disease Using Mendelian Randomization. Neurology Genetics. https://doi.org/10.1212/nxg.0000000000200307

Vancouver

Chatterjee A, Cavaillès C, Davies NM, Yaffe KS, Andrews SJ. Disentangling the Causal Effects of Education and Participation Bias on Alzheimer Disease Using Mendelian Randomization. Neurology Genetics. 2025. doi:10.1212/nxg.0000000000200307. PMID: 41235132.

BibTeX

@article{chatterjee2025-41235132,
  author  = {Chatterjee, Aadrita and Cavaillès, Clémence and Davies, Neil M and Yaffe, Kristine S. and Andrews, Shea J.},
  title   = {{Disentangling the Causal Effects of Education and Participation Bias on Alzheimer Disease Using Mendelian Randomization}},
  journal = {Neurology Genetics},
  year    = {2025},
  doi     = {10.1212/nxg.0000000000200307},
  pmid    = {41235132},
  url     = {https://doi.org/10.1212/nxg.0000000000200307}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This Mendelian randomization analysis suggested education and participation reduced Alzheimer disease risk, while education also appeared to increase risk of AD/ADRD, which the authors attribute to inconsistencies between clinical and proxy diagnoses. The authors suggest the protective effect of education may be due to other biological mechanisms such as cognitive reserve, and no treatment was tested.

Study details

How this study scored 50/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 12 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 1 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multicenter collaboration 2 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 50 of 100.50 of 100 points earned50 not earned

Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for sample size, effect reported and studied in people because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Neurology Genetics)
Journal's citation record 0 / 4 Neurology Genetics: journal h-index 53 (OpenAlex, 2026-10-29)
Study design 12 / 12 A meta-analysis pooling many studies
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 A review of other studies — randomization is not credited here
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.3 citations a year over 3 year(s) since 2025
Impact for its field and year 1 / 6 Cited 0.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Shea J. Andrews: h-index 34 (OpenAlex, whole career)
Institution's track record 2 / 3 University College London: institution h-index 2,029 (OpenAlex)
Multicenter collaboration 2 / 3 OpenAlex lists 5 institution(s) in 3 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41235132)
Free to read 2 / 2 Free to read
Total 50 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Genetics from nearby years

Also in Genetics

214 studies in the library are filed under Genetics with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Genetics hub.

Similar studies

More on Genetics

See all studies in Genetics →